Trump’s drug pricing push sidelines Medicare negotiation program
20 Articles
20 Articles
Trump’s drug pricing push sidelines Medicare negotiation program – Mnnofa
As President Donald Trump touts new deals to cut the cost of blockbuster drugs like Wegovy and Zepbound, he’s barely mentioned Medicare’s drug price negotiation program — even though the government is expected to announce lower prices before the end of the month. The program, created under President Joe Biden’s Inflation Reduction Act of 2022, gave Medicare the authority to negotiate directly with drugmakers on some of the costliest medications.…
While President Donald Trump is promoting new agreements to reduce the cost of over-the-counter drugs such as Wegovy and Zepbound, he has barely mentioned the Medicare drug price negotiation program, even though the government is expected to announce lower prices before the end of the month. The program, created under President Joe Biden’s 2022 Inflation Reduction Act, gave Medicare the power to negotiate directly with drug manufacturers some of…
Coverage Details
Bias Distribution
- 100% of the sources lean Left
Factuality
To view factuality data please Upgrade to Premium




